共 30 条
[21]
Perelson A., Et al., HIV-1 dynamics in vivo: Clearance rate, infected cell lifespan, and viral generation time, Science, 271, pp. 1582-1585, (1996)
[22]
Perelson A., Et al., The dynamics of HIV infection of CD4<sup>+</sup> T cells, Math. Biosci., 114, pp. 81-125, (1993)
[23]
Perelson A.S., Modeling the interaction of the immune system with HIV, Mathematical and Statistical Approaches to AIDS Epidemiology, Lect. Notes in Biomath., 83, pp. 350-370, (1989)
[24]
Redfield R., Burke D., HIV infection: The clinical picture, Sci. Amer., pp. 90-98, (1988)
[25]
Richman D.D., Et al., Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus, J. Acquired Immune Deficiency Syndromes, 3, pp. 743-746, (1990)
[26]
Ruffault A., Et al., The prognostic value of plasma viremia in HIV-infected patients under AXT treatment - A two-year follow-up study, J. AIDS, 9, pp. 43-248, (1995)
[27]
Vella S., Et al., Long-term follow up of AZT therapy in asymptomatic HIV infection: Results of a multicenter cohort study, J. AIDS, 7, pp. 31-38, (1994)
[28]
Volberding P.A., Et al., The duration of zidovudine benefit in persons with asymptomatic HIV infection, J. Amer. Med. Assoc., 272, pp. 437-442, (1994)
[29]
Volberding P.A., Et al., Zidovudine in asymptomatic human immunodeficiency virus infection, New England J. Med., 322, pp. 941-949, (1990)
[30]
Wei X., Et al., Viral dynamics in human immunodeficiency virus type 1 infection, Nature, 373, pp. 117-122, (1995)